- 1. GM-CSF plasmid DNA melanoma vaccine
- [A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine. ( NCI )] (UMLS (NCI) C0393071) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 16. GM-CSF/IL-2/MOAB 14G2A
- (UMLS (NCI) C0281368) =Therapeutic or Preventive Procedure
|
- 2. GM-CSF plasmid DNA pancreatic tumor cell vaccine
- [A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0677758) =Pharmacologic Substance; Immunologic Factor ;
| - 17. GM-CSF/IL-2/MOAB 3622W94
- (UMLS (NCI) C0677997) =Therapeutic or Preventive Procedure
|
- 3. GM-CSF plasmid DNA sarcoma vaccine
- [An autologous sarcoma cell vaccine with potential immunostimulatory activity. Tumor cells harvested from a patient with sarcoma are transfected with a plasmid DNA encoding for human sargramostim (GM-CSF) using a particle-mediated gene transfer (PMGT) technique, which avoids the use infectious components. Vaccination with an autologous sargramostim sarcoma vaccine produces high levels of GM-CSF, a cytokine that enhances antigen presentation by activated macrophages and increases the recognition of weakly immunogenic tumors by cytotoxic T-lymphocytes. ( NCI )] (UMLS (NCI) C0393070) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 18. GM-CSF/IL-2/VBL
- (UMLS (NCI) C0677982) =Therapeutic or Preventive Procedure
|
- 4. GM-CSF/gp100/IFA
- (UMLS (NCI) C0677818) =Therapeutic or Preventive Procedure
| - 19. GM-CSF/IL-6
- (UMLS (NCI) C0281625) =Therapeutic or Preventive Procedure
|
- 5. GM-CSF/GP100/IFA/MART-1/TYRP
- (UMLS (NCI) C0677812) =Therapeutic or Preventive Procedure
| - 20. GM-CSF/IL3 Fusion Protein
- [A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines. This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells. (NCI04) ( NCI )] (UMLS (NCI) C0211169) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 6. GM-CSF/IFA/TRP-1
- (UMLS (NCI) C0677822) =Therapeutic or Preventive Procedure ;
| - 21. GM-CSF/L-PAM
- (UMLS (NCI) C0279312) =Therapeutic or Preventive Procedure
|
- 7. GM-CSF/IFA/TYRP
- (UMLS (NCI) C0677819) =Therapeutic or Preventive Procedure
| - 22. GM-CSF/MOAB 3F8
- (UMLS (NCI) C0281630) =Therapeutic or Preventive Procedure
|
- 8. GM-CSF/IFA/VHL peptide
- (UMLS (NCI) C0796339) Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine;
=Therapeutic or Preventive Procedure | - 23. GM-CSF/MOAB R24
- (UMLS (NCI) C0280903) =Therapeutic or Preventive Procedure
|
- 9. GM-CSF/IFN-A
- (UMLS (NCI) C0796391) Interferon Alfa/Sargramostim;
=Therapeutic or Preventive Procedure | - 24. GM-CSF/NM/PCB/PRED/VCR
- (UMLS (NCI) C0280639) =Therapeutic or Preventive Procedure
|
- 10. GM-CSF/IFN-A/IL-2
- (UMLS (NCI) C0796334) Interferon Alfa/Interleukin-2/Sargramostim;
=Therapeutic or Preventive Procedure | - 25. GM-CSF/PRED/VCR
- (UMLS (NCI) C0279310) =Therapeutic or Preventive Procedure
|
- 11. GM-CSF/IFN-A/ZDV
- (UMLS (NCI) C0338086) =Therapeutic or Preventive Procedure
| - 26. GM-CSF/PXT
- (UMLS (NCI) C0280939) =Therapeutic or Preventive Procedure
|
- 12. GM-CSF/IFN-G
- (UMLS (NCI) C0280713) =Therapeutic or Preventive Procedure ;
| - 27. GM-CSF/TNF
- (UMLS (NCI) C0281569) =Therapeutic or Preventive Procedure ;
|
- 13. GM-CSF/IFN-G/IL-1B/IL-2/TNF
- (UMLS (NCI) C0392981) =Therapeutic or Preventive Procedure
| - 28. GM-CSF/TSPA
- (UMLS (NCI) C0214035) =Therapeutic or Preventive Procedure
|
- 14. GM-CSF/IL-11
- (UMLS (NCI) C0678045) =Therapeutic or Preventive Procedure ;
| - 29. GM-CSF/ZDV
- (UMLS (NCI) C0279293) =Therapeutic or Preventive Procedure ;
|
- 15. GM-CSF/IL-2
- (UMLS (NCI) C0280714) =Therapeutic or Preventive Procedure ;
| |
home
